PMC:7102662 / 1650-2103 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"T18","span":{"begin":144,"end":150},"obj":"Disease"},{"id":"T19","span":{"begin":202,"end":210},"obj":"Disease"},{"id":"T20","span":{"begin":295,"end":301},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":36,"end":37},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":38,"end":57},"obj":"Phenotype"},{"id":"T5","span":{"begin":172,"end":198},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002086"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}

{"project":"LitCovid-sentences","denotations":[{"id":"T18","span":{"begin":0,"end":10},"obj":"Sentence"},{"id":"T19","span":{"begin":11,"end":126},"obj":"Sentence"},{"id":"T20","span":{"begin":127,"end":240},"obj":"Sentence"},{"id":"T21","span":{"begin":241,"end":368},"obj":"Sentence"},{"id":"T22","span":{"begin":369,"end":453},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T22","span":{"begin":14,"end":22},"obj":"SP_7"},{"id":"T23","span":{"begin":38,"end":49},"obj":"UBERON:0001004"},{"id":"T24","span":{"begin":62,"end":76},"obj":"UBERON:0004535"},{"id":"T25","span":{"begin":136,"end":143},"obj":"UBERON:0000948"},{"id":"T26","span":{"begin":172,"end":186},"obj":"UBERON:0004535"},{"id":"T27","span":{"begin":202,"end":210},"obj":"SP_7"},{"id":"T28","span":{"begin":287,"end":294},"obj":"UBERON:0000948"},{"id":"T29","span":{"begin":396,"end":410},"obj":"UBERON:0004535"},{"id":"T28939","span":{"begin":14,"end":22},"obj":"SP_7"},{"id":"T63068","span":{"begin":38,"end":49},"obj":"UBERON:0001004"},{"id":"T50637","span":{"begin":62,"end":76},"obj":"UBERON:0004535"},{"id":"T71297","span":{"begin":136,"end":143},"obj":"UBERON:0000948"},{"id":"T53229","span":{"begin":172,"end":186},"obj":"UBERON:0004535"},{"id":"T43385","span":{"begin":202,"end":210},"obj":"SP_7"},{"id":"T70797","span":{"begin":287,"end":294},"obj":"UBERON:0000948"},{"id":"T36063","span":{"begin":396,"end":410},"obj":"UBERON:0004535"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}

{"project":"LitCovid-PubTator","denotations":[{"id":"58","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"59","span":{"begin":38,"end":57},"obj":"Disease"},{"id":"63","span":{"begin":136,"end":150},"obj":"Disease"},{"id":"64","span":{"begin":172,"end":198},"obj":"Disease"},{"id":"65","span":{"begin":202,"end":210},"obj":"Disease"},{"id":"69","span":{"begin":359,"end":367},"obj":"Species"},{"id":"70","span":{"begin":255,"end":258},"obj":"Disease"},{"id":"71","span":{"begin":287,"end":301},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C000657245"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D012140"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D006331"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D002318"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:C000657245"},{"id":"A69","pred":"tao:has_database_id","subj":"69","obj":"Tax:9606"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:D002318"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D006331"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Highlights\n• COVID-19 is primarily a respiratory illness but cardiovascular involvement can occur through several mechanisms.\n• Acute cardiac injury is the most reported cardiovascular abnormality in COVID-19, with average incidence 8-12%\n• Underlying CVD and/or development of acute cardiac injury are associated with significantly worse outcome in these patients.\n• Information about other cardiovascular manifestations is very limited at present."}